420 related articles for article (PubMed ID: 28019031)
21. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
22. New ultraviolet C light-based method for pathogen inactivation of red blood cell units.
Handke W; Gravemann U; Müller TH; Wagner FF; Schulze TJ; Seltsam A
Transfusion; 2022 Nov; 62(11):2314-2323. PubMed ID: 36087025
[TBL] [Abstract][Full Text] [Related]
23. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution?
van der Meer PF; Bontekoe IJ; Daal BB; de Korte D
Transfusion; 2015 Aug; 55(8):1900-8. PubMed ID: 25752624
[TBL] [Abstract][Full Text] [Related]
24. Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro.
Zeddies S; De Cuyper IM; van der Meer PF; Daal BB; de Korte D; Gutiérrez L; Thijssen-Timmer DC
Transfusion; 2014 Sep; 54(9):2292-300. PubMed ID: 24689812
[TBL] [Abstract][Full Text] [Related]
25. The expression of CD47 and its association with 2,3-DPG levels in stored leuco-reduced blood units.
Eldesouky NA; Abo El Fetouh RM; Hafez AA; Gad A; Kamal MM
Transfus Clin Biol; 2019 Nov; 26(4):279-283. PubMed ID: 30713045
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Histones Induced Eryptotic Death in Human Erythrocytes.
Yeung KW; Lau PM; Tsang HL; Ho HP; Kwan YW; Kong SK
Cell Physiol Biochem; 2019; 53(1):229-241. PubMed ID: 31302949
[TBL] [Abstract][Full Text] [Related]
27. Metabolic rejuvenation upgrades circulatory functions of red blood cells stored under blood bank conditions.
Marin M; Roussel C; Dussiot M; Ndour PA; Hermine O; Colin Y; Gray A; Landrigan M; Le Van Kim C; Buffet PA; Amireault P
Transfusion; 2021 Mar; 61(3):903-918. PubMed ID: 33381865
[TBL] [Abstract][Full Text] [Related]
28. Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres.
van der Meer PF; Couture C; Hervig T; Kruit G; Devine DV; de Korte D; Kerkhoffs JL
Vox Sang; 2017 Jan; 112(1):9-17. PubMed ID: 28001293
[TBL] [Abstract][Full Text] [Related]
29. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
30. In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage.
Picker SM; Radojska SM; Gathof BS
Transfusion; 2007 Apr; 47(4):687-96. PubMed ID: 17381628
[TBL] [Abstract][Full Text] [Related]
31. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
Picker SM; Steisel A; Gathof BS
Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
[TBL] [Abstract][Full Text] [Related]
32. The effects of rejuvenation during hypothermic storage on red blood cell membrane remodeling.
Kurach JD; Almizraq R; Bicalho B; Acker JP; Holovati JL
Transfusion; 2014 Jun; 54(6):1595-603. PubMed ID: 24224647
[TBL] [Abstract][Full Text] [Related]
33. Red blood cell age determines the impact of storage and leukocyte burden on cell adhesion molecules, glycophorin A and the release of annexin V.
Sparrow RL; Healey G; Patton KA; Veale MF
Transfus Apher Sci; 2006 Feb; 34(1):15-23. PubMed ID: 16377250
[TBL] [Abstract][Full Text] [Related]
34. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
[TBL] [Abstract][Full Text] [Related]
35. The effects of an overnight holding of whole blood at room temperature on haemoglobin modification and in vitro markers of red blood cell aging.
Eckstein M; Zimmermann R; Roth T; Hauck-Dlimi B; Strasser EF; Xiang W
Vox Sang; 2015 May; 108(4):359-67. PubMed ID: 25753392
[TBL] [Abstract][Full Text] [Related]
36. Sublytic Terminal Complement Components Induce Eryptosis in Autoimmune Haemolytic Anaemia Related to IgM Autoantibodies.
Balola AHA; Mayer B; Bartolmäs T; Salama A
Cell Physiol Biochem; 2019; 53(3):453-464. PubMed ID: 31448885
[TBL] [Abstract][Full Text] [Related]
37. Quality control of riboflavin-treated platelet concentrates using Mirasol® PRT system: Polish experience.
Lachert E; Kubis J; Antoniewicz-Papis J; Rosiek A; Woźniak J; Piotrowski D; Przybylska Z; Mikołowska A; Marschner S; Łętowska M
Adv Clin Exp Med; 2018 Jun; 27(6):765-772. PubMed ID: 29877637
[TBL] [Abstract][Full Text] [Related]
38. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
Balint B; Jovicic-Gojkov D; Todorovic-Balint M; Subota V; Pavlovic M; Goodrich R
Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
[TBL] [Abstract][Full Text] [Related]
39. Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.
Okoye OT; Reddy H; Wong MD; Doane S; Resnick S; Karamanos E; Skiada D; Goodrich R; Inaba K
Transfusion; 2015 Mar; 55(3):532-43. PubMed ID: 25582335
[TBL] [Abstract][Full Text] [Related]
40. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
Picker SM; Steisel A; Gathof BS
Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
